← Leaderboards
Louis B Nabors
University Of Alabama At Birmingham
$6,698,272
Attributed
$8,935,728
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $797.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,935,728 · 10
By mechanism
R01$3,455,479 · 3
U10$1,988,385 · 1
U24$1,484,430 · 1
P30$796,394 · 3
R21$652,500 · 1
U01$558,540 · 1
Top collaborators
- Khurram Bashir12 shared
- Natalia Filippova3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- James M Markert$5,310,460
- Frank Furnari$6,666,697
- Corinne E. Griguer$4,854,691
- Richard J. Whitley$15,110,969
- Jiangbing Zhou$16,453,834
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsResearch PersonnelGliomaLaboratoriesClinical TrialsClinical ResearchAlabamaLeadershipPhysiciansSuccessFacultyClinical ProtocolsResourcesTranslational ResearchTumorLeadMalignant NeoplasmsNeurosciencesTranslatingUniversitiesResearch InfrastructureSiteBaseDesign
Grant awards (37)
03 - Neuro-Oncology$457,959
P30 · FY2025 · CA · contact PI
ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation$339,694
R01 · FY2025 · CA · contact PI
ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation$322,710
R01 · FY2024 · CA · contact PI
03 - Neuro-Oncology$62,455
P30 · FY2024 · CA · contact PI
ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation$339,694
R01 · FY2023 · CA · contact PI
03 - Neuro-Oncology$62,453
P30 · FY2023 · CA · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$296,886
U24 · FY2022 · NS · contact PI
03 - Neuro-Oncology$62,453
P30 · FY2022 · CA · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$296,886
U24 · FY2021 · NS · contact PI
04 Neuro-Oncology Program$31,883
P30 · FY2021 · CA · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$296,886
U24 · FY2020 · NS · contact PI
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma$262,808
R01 · FY2020 · CA · contact PI
04 Neuro-Oncology Program$119,191
P30 · FY2020 · CA · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$296,886
U24 · FY2019 · NS · contact PI
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma$253,739
R01 · FY2019 · CA · contact PI
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma$342,804
R01 · FY2018 · CA · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$296,886
U24 · FY2018 · NS · contact PI
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma$336,380
R01 · FY2017 · CA · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$293,000
U10 · FY2017 · NS · contact PI
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma$348,129
R01 · FY2016 · CA · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$293,000
U10 · FY2016 · NS · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$261,700
U10 · FY2015 · NS · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$293,000
U10 · FY2014 · NS · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$261,685
U10 · FY2013 · NS · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$293,000
U10 · FY2012 · NS · contact PI
Network of Excellence in Neuroscience Clinical Trials (NEXT)$293,000
U10 · FY2011 · NS · contact PI
Post-transcriptional Regulation Requires Phosphorylation of HuR in Glioma$225,695
R01 · FY2009 · CA · contact PI
Post-transcriptional Regulation Requires Phosphorylation of HuR in Glioma$225,695
R01 · FY2008 · CA · contact PI
Therapeutic Studies of Anaplastic Gliomas$119,037
U01 · FY2008 · CA · contact PI
Post-transcriptional Regulation Requires Phosphorylation of HuR in Glioma$225,695
R01 · FY2007 · CA · contact PI
Therapeutic Studies of Anaplastic Gliomas$115,818
U01 · FY2007 · CA · contact PI
Post-transcriptional Regulation Requires Phosphorylation of HuR in Glioma$232,436
R01 · FY2006 · CA · contact PI
Therapeutic Studies of Anaplastic Gliomas (John Hopkins*$117,841
U01 · FY2006 · CA · contact PI
Therapeutic Studies of Anaplastic Gliomas (John Hopkins*$117,163
U01 · FY2005 · CA
Endpoint Analyses of Anti-Integrin Therapy for Gliomas$326,250
R21 · FY2004 · CA
Therapeutic Studies of Anaplastic Gliomas$88,681
U01 · FY2004 · CA
Endpoint Analyses of Anti-Integrin Therapy for Gliomas$326,250
R21 · FY2003 · CA